Skip to content

Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycaemic Levels

Formulation and Assessment of Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycemic Levels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06095622
Acronym
DP-Trails
Enrollment
12
Registered
2023-10-23
Start date
2023-03-15
Completion date
2023-08-30
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Metabolism Disorders (Including Diabetes Mellitus)

Keywords

Chickpea pulao, Fenugreek seeds, Indian rennet, Glucose modulating

Brief summary

The goal of this study was to perform a clinical trial to compare the impact of herbal chickpea pulao (cooked Indian-Pakistani rice dish) on improving postprandial blood glucose levels in type-2 diabetic people. The main questions it aims to answer are: * Whether Indian rennet and fenugreek seed extract can modulate blood sugar levels or not? * At what concentration the flavor, taste, and blood sugar impact were acceptable? Participants were provided with control and intervention herbal chickpea pulao for a period of 21 days and asked to provide feedback on taste, flavor, and over-acceptability, and their postprandial blood glucose levels were checked.

Interventions

DIETARY_SUPPLEMENTFenugreek Seeds and Indian Rennet

Food herbs like fenugreek Seeds and Indian rennet to formulate rice dish.

Sponsors

University of Management and Technology Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* People having Type-2 diabetes disease * Must be able to consume chickpea rice pulao * Must not be on vegan or keto diet

Exclusion criteria

* Healthy people without diabetes * People with less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Improvement in blood glucose levels21 daysIncrease or decrease in postprandial glucose levels in mg/dL.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026